Healthcare Triangle, Inc. / Fundamentals
Income statement
- Net revenue
€10.22M - Cost of goods sold
€8.67M - Gross profit
€1.55M - SG&A expenses
€5.11M - R&D expenses
€253.30K - EBITDA
-€3.52M - D&A
€181.10K - EBIT
-€3.81M - Interest expenses
€1.18M - EBT
-€4.88M - Tax expenses
€5.17K - Net income
-€4.88M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€1.03M - Changes in working capital
-€3.54M - Operating cash flow
-€7.14M - Capex
€0.00 - Other investing cash flow
€0.00 - Net investing cash flow
-€519.51K - Total cash dividends paid
€0.00 - Issuance of common stock
€10.98M - Debt repayment
-€543.64K - Other financing cash flow
-€823.64K - Net financing cash flow
€10.42M - Foreign exchange effects
€0.00 - Net change in cash
€2.76M - Cash at end of period
€2.78M - Free cash flow
-€7.14M
Balance sheet
- Cash and cash equivalents
€2.78M - Cash and short-term investments
€2.78M - Total receivables
€4.46M - Inventory
€0.00 - Other current assets
€392.00K - Total current assets
€7.64M - Property, plant & equipment
€2.58K - Goodwill
€0.00 - Intangible assets
€4.91M - Long-term investments
€0.00 - Other non-current assets
€0.00 - Total non-current assets
€4.91M - Total assets
€12.55M - Accounts payable
€1.79M - Short-term debt
€357.54K - Other current liabilities
€577.24K - Total current liabilities
€2.72M - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
€1.03M - Total non-current liabilities
€1.03M - Total liabilities
€3.76M - Common stock
€12.06K - Retained earnings
-€31.57M - Other equity
€0.00 - Total equity
€8.80M - Total liabilities and shareholders' equity
€12.55M
Company information
- Market capitalization
€8.05M - Employees
36 - Enterprise Value
€6.39M
Company ratios
- Gross margin
-
15.2% Much worse than peer group: 45.8% - EBITDA margin
-
-34.4% Much better than peer group: -23,783.3% - EBIT margin
-
-37.3% Much better than peer group: -25,163.2% - EBT margin
-
-47.7% Much better than peer group: -26,810.6% - Net margin
-
-47.7% Much better than peer group: -26,805.0% - ROE
-
-55.5% Much worse than peer group: 6,980.7% - ROA
-
-38.9% Much better than peer group: -330.5% - Asset turnover
-
81.4% Much better than peer group: 14.8% - FCF margin
-
-69.9% Much better than peer group: -19,637.6% - FCF yield
-88.7% - Efficiency ratio
134.4% - Net sales per employee
-
€283.95K - Net income per employee
-
-€135.57K